Patient-Reported Outcomes from the Positive Phase 3 monarchE Trial for Verzenio® at St. Gallen Virtual Congress 2021
The Pharma Data
MARCH 17, 2021
In estrogen receptor-positive (ER+) breast cancer cell lines, cyclin D1 and CDK4 & 6 promote phosphorylation of the retinoblastoma protein (Rb), cell cycle progression, and cell proliferation. Symptoms may include hypoxia, cough, dyspnea, or interstitial infiltrates on radiologic exams.
Let's personalize your content